Sarah J Danson

15PUBLICATIONS
102CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 09, 2026
Ceralasertib plus durvalumab in Ras mutant and Ras wild type advanced non-small cell lung cancer: Two cohorts of the phase II platform National Lung Matrix Trial.

|May 29, 2026
Cancer vaccines: comprehensive review.

|May 14, 2026
Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction.

|May 04, 2026
Exercise Boosts the Immune System and Enhances Immunotherapy Responses in Pancreatic Cancer and Mesothelioma.

|Mar 05, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Elizabeth M Gaughan, Miso Kim, Ignacio Mendez

|Jan 12, 2026
The UK vaccine innovation pathway.

Sarah Danson, Robert P Jones, Kristina Duggleby

Pageof 3

Frequent Collaborators

3 joint publications

Greg Wells

2 joint publications

Samantha Conroy

2 joint publications

Spencer J Collis

2 joint publications

Juha Rantala